What is Adaptive Biotechnologies's change in AP?

Adaptive Biotechnologies (ADPT) reported change in AP of -$7.51M in Q1 2026.

How has Adaptive Biotechnologies's change in AP changed year-over-year?

Adaptive Biotechnologies's change in AP increased by 22.3% year-over-year, from -$9.67M to -$7.51M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Adaptive Biotechnologies ADPT Change in AP

Change in AP at other companies

Natera, Inc.NTRA

$21.88M+820%

Monte Rosa Therapeutics, Inc.GLUE

$4.38M+140%

GeneDx HoldingsWGS

-$13.17M-222%

VeracyteVCYT

$2.59M-63.7%

Nurix Therapeutics, Inc.NRIX

-$461K+85.6%

DanaherDHR

-$41M+32.8%

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's change in AP?: Adaptive Biotechnologies (ADPT) reported change in AP of -$7.51M in Q1 2026.
How has Adaptive Biotechnologies's change in AP changed year-over-year?: Adaptive Biotechnologies's change in AP increased by 22.3% year-over-year, from -$9.67M to -$7.51M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.